Fresh Tracks Therapeutics (NASDAQ:FRTX) Shares Down 0.3% – What’s Next?

Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTXGet Free Report)’s stock price dropped 0.3% during trading on Monday . The stock traded as low as $0.93 and last traded at $0.93. Approximately 1,328 shares were traded during trading, a decline of 51% from the average daily volume of 2,735 shares. The stock had previously closed at $0.93.

Fresh Tracks Therapeutics Trading Down 0.3 %

The firm has a market capitalization of $5.55 million, a price-to-earnings ratio of -0.66 and a beta of 0.54. The firm’s 50-day moving average is $0.78 and its 200 day moving average is $0.77.

About Fresh Tracks Therapeutics

(Get Free Report)

Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.

Recommended Stories

Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.